DRI Healthcare Trust Declares Special Distributions
TORONTO, Dec. 22, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that its Board of Trustees has declared a special cash distribution in the amount of US$0.22 per trust unit. The special cash distribution will be made payable to unitholders of record at the close of business […]
DRI Healthcare Trust Comments on Extension of Review Period for pacritinib
TORONTO, Nov. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that it has been notified by CTI BioPharma Corp. (CTI) that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application for pacritinib for the treatment of adult Myelofibrosis […]
DRI Healthcare Trust Reports Third Quarter 2021 Results and Announces Increase to Quarterly Distribution
– Continued strong performance of core royalty assets – – Demonstrated growth strategy execution through two transactions valued at up to $185 million – – Quarterly distribution doubled to US$0.075 per unit – TORONTO, Nov. 8, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its results for […]
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 9, 2021
TORONTO, Oct. 25, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its 2021 third quarter financial results on Tuesday, November 9, 2021, at 8:30 a.m. ET. The Trust will report its financial results on Monday, November 8, 2021, after […]
DRI Healthcare Trust Announces US$200 Million Credit Facility
TORONTO, Oct. 22, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into a credit agreement with a syndicate of banks regarding US$200 million of revolving credit facilities (“the Facilities”). An initial draw on the Facilities will be used to […]
DRI Healthcare Trust Announces Acceptance by TSX of Normal Course Issuer Bid
TORONTO, Sept. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today the acceptance by the Toronto Stock Exchange (the “TSX”) of the Trust’s Notice of Intention to make a normal course issuer bid (the “NCIB”). Pursuant to the NCIB, the Trust proposes to purchase, from time to time, if […]
DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®
– Oracea® is the only branded oral prescription medication indicated for papulopustular rosacea – TORONTO, Sept. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that a wholly-owned subsidiary of DRI has acquired a royalty interest in Oracea® for a net purchase price of US$46.4 million. “We are […]
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction
– Transaction to Fund Launch and Commercialization of Pacritinib in the United States This Year Pending FDA Approval, and Future Commercialization – SEATTLE and TORONTO, Aug. 25, 2021 /CNW/ – CTI BioPharma Corp. (Nasdaq: CTIC) (CTI) and DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (DRI) today announced transactions totaling up to $135 million in funding for […]
DRI Healthcare Trust to Host Conference Call to Discuss Transaction Announcement
– Conference call to be held Wednesday, August 25, 2021 at 1:30 pm ET – TORONTO, Aug. 25, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that it will be conducting a conference call to discuss the Trust’s previously announced debt and royalty transaction with CTI BioPharma Corp. […]
DRI Healthcare Trust Reports Second Quarter 2021 Results
– Quarter highlighted by strong performance from existing pharmaceutical products portfolio – TORONTO, Aug. 5, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its results for the quarter ended June 30, 2021. The Trust’s second quarter 2021 financial statements and Management’s Discussion & Analysis have been filed […]